Pancreatic Cancer Research

ResearcherZhengzhou UniversityActive in the last 2 years

Tao Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2607-8407; OpenAlex author ID A5103008911, A5122577403. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. c-Myc/GRPEL1 maintains fatty acid synthesis via FASN to support PDAC cell proliferation. Co-author DOI 10.1038/s41419-026-08439-0↗
  2. The Scavenger Receptor MARCO Expressed by Tumor-Associated Macrophages Are Highly Associated With Poor Pancreatic Cancer Prognosis. Co-author DOI 10.3389/fonc.2021.771488↗
  3. Paeoniflorin inhibits human pancreatic cancer cell apoptosis via suppression of MMP-9 and ERK signaling. Co-author DOI 10.3892/ol.2016.4761↗
  4. Expression of long non-coding RNA LOC285194 and its prognostic significance in human pancreatic ductal adenocarcinoma. Last author PMID 25550852↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jing Wang · 1 shared paper, 2026 · strength 0.28
  2. Feng Chen · 1 shared paper, 2026 · strength 0.28
  3. Wei Cui · 1 shared paper, 2026 · strength 0.28
  4. Hezhi Fang · 1 shared paper, 2026 · strength 0.28
  5. Bian Shi · 1 shared paper, 2021 · strength 0.14
  6. Suxia Luo · 1 shared paper, 2021 · strength 0.14
  7. Yi Zhou · 1 shared paper, 2016 · strength 0.07
  8. Jinxue Zhou · 1 shared paper, 2016 · strength 0.07
  9. Feng Han · 1 shared paper, 2016 · strength 0.07
  10. Nanmu Yang · 1 shared paper, 2016 · strength 0.07
  11. Yuechao Ding · 1 shared paper, 2014 · strength 0.05
  12. Chao Ma · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.